An SMS-Guided Basal Insulin Titration in People with Type 2 Diabetes New on Insulin Tim SnelSven ReinhardtGuido Freckmann Brief Report Open access 30 September 2024 Pages: 2429 - 2441
Comparison of the Risk of Diabetic Retinopathy Between Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus in Japan: A Retrospective Analysis of Real-World Data Masaya KoshizakaTomoaki TatsumiMami Shintani-Tachi Original Research Open access 30 September 2024 Pages: 2401 - 2416
Quality of Life in Japanese People with Type 2 Diabetes Switching from Multiple Daily Insulin Injections to Once-Daily iGlarLixi: SIMPLIFY Japan Hitoshi IshiiHideki KamiyaDaisuke Yabe Original Research Open access 30 September 2024 Pages: 2381 - 2400
Perspectives and Preferences of People with Type 2 Diabetes for the Attributes of Weekly Insulin Felicia T. GelseyDavid SchapiroCarol Mansfield Original Research Open access 30 September 2024 Pages: 2367 - 2379
Criteria for Personalised Choice of a Continuous Glucose Monitoring System: An Expert Opinion Sergio Di MolfettaAntonio RossiDaniela Bruttomesso Commentary Open access 30 September 2024 Pages: 2263 - 2278
Rationale and Design of the Study to Investigate the Metabolic Action of Imeglimin on Patients with Type 2 Diabetes Mellitus (SISIMAI) Tsubasa TajimaHideyoshi KagaHirotaka Watada Study Protocol Open access 30 September 2024
12-Month Time in Tight Range Improvement with Advanced Hybrid-Closed Loop System in Adults with Type 1 Diabetes Laura NigiMaria De Los Angeles Simon BatzibalFrancesco Dotta Brief Report Open access 30 September 2024
Insulin Delivery Technology for Treatment of Infants with Neonatal Diabetes Mellitus: A Systematic Review Raffaella PanzaValentina CattiveraMaurizio Delvecchio Review Open access 18 September 2024 Pages: 2293 - 2308
Correction to: Comparative Efficacy and Safety of Tirzepatide in Asians and Non-Asians with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis Yuying CuiJinming YaoLin Liao Correction Open access 16 September 2024 Pages: 2443 - 2443
Efficacy and Safety of Pioglitazone/Metformin Fixed-Dose Combination Versus Uptitrated Metformin in Patients with Type 2 Diabetes without Adequate Glycemic Control: A Randomized Clinical Trial Li-xin GuoLian-wei WangJun-Ting Duan Original Research Open access 16 September 2024 Pages: 2351 - 2366
Intervening on Metabolic Dysfunction-Associated Steatotic Liver Disease in Latino/a and Black Patients with Diabetes: A Feasibility Pilot Anastasia-Stefania AlexopoulosSusanne DanusMatthew J. Crowley Brief Report Open access 14 September 2024 Pages: 2417 - 2427
Real-Life Effectiveness of iGlarLixi (Insulin Glargine 100 U/ml and Lixisenatide) in People with Type 2 Diabetes (T2D) According to Baseline HbA1c and BMI Janos T. KisJochen SeufertCristian Guja Original Research Open access 14 September 2024 Pages: 2337 - 2350
Differential Efficacy of Weight Loss Interventions in Patients with Versus Without Diabetes Federico Losada-DíazSantiago Lizarazo-BocanegraCarlos O. Mendivil Review Open access 14 September 2024 Pages: 2279 - 2291
The Effects of Imeglimin on Muscle Strength in Patients with Type 2 Diabetes: A Prospective Cohort Study Takeshi OyanagiShin KawanabeMasakatsu Sone Original Research Open access 09 September 2024 Pages: 2323 - 2336
Safety and Effectiveness of Concomitant iGlarLixi and SGLT-2i Use in People with T2D During Ramadan Fasting: A SoliRam Study Sub-analysis Mohamed HassaneinRachid MalekInass Shaltout Original Research Open access 09 September 2024 Pages: 2309 - 2322
Publisher Correction to: ISIS 449884 Injection Add‑On to Metformin in Patients with Type 2 Diabetes: A Randomized, Double‑Blind, Placebo‑Controlled, Phase II Clinical Study Linong JiLeili GaoLi-Ming Gan Publisher Correction Open access 29 August 2024 Pages: 2197 - 2197
Insights into Knowledge and Attitudes About Autoantibody Screening from People Affected by Type 1 Diabetes: A Brief Report Caitlin S. KellyWendy A. WolfJessica L. Dunne Brief Report Open access 27 August 2024 Pages: 2249 - 2261
Targeting Autophagy: A Promising Therapeutic Strategy for Diabetes Mellitus and Diabetic Nephropathy Qi-Rui LiHui-Ying XuMei-Juan Chen Review Open access 21 August 2024 Pages: 2153 - 2182
A Randomized Controlled Trial on the Effect of Luseogliflozin on Bone Microarchitecture Evaluated Using HR-pQCT in Elderly Type 2 Diabetes Riyoko ShigenoIchiro HorieNorio Abiru Brief Report Open access 17 August 2024 Pages: 2233 - 2248
The Association of HbA1c Variability with 12 Week and 12 Month Outcomes on Diabetes Related Foot Ulcer Healing Georgia ThomasonCatherine GoodayKetan Dhatariya Original Research Open access 17 August 2024 Pages: 2223 - 2232
Correction to: Safety and Psychological Outcomes of Tandem t:Slim X2 Insulin Pump with Control-IQ Technology in Children, Adolescents, and Young Adults with Type 1 Diabetes: A Systematic Review Chiara MameliGiulia Marie SmylieMaurizio Delvecchio Correction Open access 14 August 2024 Pages: 2151 - 2151
Transition from Paediatric to Adult Diabetes Care in People with Type 1 Diabetes: An Online Survey from France Juliette EroukhmanoffClaire Ballot SchmitEric Renard Original Research Open access 10 August 2024 Pages: 2211 - 2222
Forecasting Trial Milestones: A Predictive Analysis for Early Termination of the SOUL Study Binayak SinhaSamit Ghosal Original Research Open access 08 August 2024 Pages: 2199 - 2209
Efficacy and Safety of Escalating the Dose of Oral Semaglutide from 7 to 14 mg: A Single-Center, Retrospective Observational Study Genki SatoHiroshi UchinoTakahisa Hirose Original Research Open access 07 August 2024 Pages: 2119 - 2130
Flash Glucose Monitoring is Associated with HbA1c Improvement in Type 2 Diabetes Managed with Multiple Daily Injections of Insulin in the UK: A Retrospective Observational Study Karen A. AdamsonFraser W. GibbAnna Strzelecka Original Research Open access 05 August 2024 Pages: 2109 - 2118
Medication-Induced Hyperglycemia and Diabetes Mellitus: A Review of Current Literature and Practical Management Strategies Akshay B. JainValerie Lai Review Open access 31 July 2024 Pages: 2001 - 2025
Tirzepatide: A Double Agonist for Various People Living with Type 2 Diabetes Felice StrolloGiuseppina GuarinoSandro Gentile Commentary Open access 31 July 2024 Pages: 1855 - 1860
Interaction Between Primary Hyperlipidemias and Type 2 Diabetes: Therapeutic Implications Rafael ZubiránIvette Cruz-BautistaCarlos A. Aguilar-Salinas Review Open access 30 July 2024 Pages: 1979 - 2000
The Effects of Bariatric Surgery on the Requirement for Antihypertensive Treatment in Type 2 Diabetes: Insights from a Long-Term Follow-Up Study Adrian HealdFahmida MannanHandrean Soran Original Research Open access 27 July 2024 Pages: 2097 - 2107
PIONEER REAL Sweden: A Multicentre, Prospective, Real-World Observational Study of Oral Semaglutide Use in Adults with Type 2 Diabetes in Swedish Clinical Practice Sergiu-Bogdan CatrinaHanan AmadidStefan Jansson Original Research Open access 25 July 2024 Pages: 2079 - 2095
Effect of Replacing Sucrose in Beverages with Nonnutritive Sweetener Sucralose on Cardiometabolic Risk Factors Among Asian Indian Adults with Type 2 Diabetes: A 12-Week Randomized Controlled Trial Viswanathan MohanValangaiman Sriram ManasaVasudevan Sudha Original Research Open access 24 July 2024 Pages: 2061 - 2077
Intentional Insulin Overdose and Depression in Subjects with and Without Diabetes Mellitus: A Commentary Evanthia GouveriAikaterini GkouveriNikolaos Papanas Commentary Open access 24 July 2024 Pages: 1845 - 1854
Suitability and Usefulness of a Flexible Dosing Timing of Oral Semaglutide to Maximize Benefit in Clinical Practice: An Expert Panel Riccardo CandidoChiara Di LoretoGian Paolo Fadini Review Open access 22 July 2024 Pages: 1963 - 1977
Summary of Research: Cardiovascular and Kidney Outcomes with Finerenone in Patients with Type 2 Diabetes and Chronic Kidney Disease—The FIDELITY Pooled Analysis Karin HumleBoris KlangerNichole Jefferson Summary of Research Open access 19 July 2024 Pages: 1861 - 1864
Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review Subodh VermaLawrence A. LeiterMarc P. Bonaca Review Open access 18 July 2024 Pages: 1893 - 1961
Correction to: Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study Pierre GourdyPatrice DarmonAlfred Penfornis Correction Open access 15 July 2024 Pages: 2131 - 2132
Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6) Kristina Secnik BoyeJiat Ling PoonHiren Patel Original Research Open access 15 July 2024 Pages: 2039 - 2059
Association of Changes in A1C Following Continuous Glucose Monitoring Acquisition in People with Sub-Optimally Treated Type 2 Diabetes Taking GLP-1 RA Therapy Eden MillerJoyce S. ChuangEugene E. Wright Jr. Original Research Open access 15 July 2024 Pages: 2027 - 2038
ISIS 449884 Injection Add-On to Metformin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Study Linong JiLeili GaoLi-Ming Gan Original Research Open access 15 July 2024 Pages: 2183 - 2196
Safety and Psychological Outcomes of Tandem t:Slim X2 Insulin Pump with Control-IQ Technology in Children, Adolescents, and Young Adults with Type 1 Diabetes: A Systematic Review Chiara MameliGiulia Marie SmylieMaurizio Delvecchio Review Open access 15 July 2024 Pages: 2133 - 2149
Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group Andrej JanezEmir MuzurovicManfredi Rizzo Review Open access 11 July 2024 Pages: 1865 - 1892
Evaluation of Cardiovascular Risk in People with Type 1 Diabetes: A Comprehensive and Specific Proposed Practical Approach Clara ViñalsIgnacio CongetAntonio J. Amor Practical Approach Open access 08 July 2024 Pages: 1831 - 1844
Risk of Urogenital Bacterial Infection with Sodium-Glucose Cotransporter-2 Inhibitors: A Retrospective Cohort Study Using a Claims Database Takanori ImaiNaoto KatoShuji Hatakeyama Original Research Open access 03 July 2024 Pages: 1821 - 1830
Current Position of Gliclazide and Sulfonylureas in the Contemporary Treatment Paradigm for Type 2 Diabetes: A Scoping Review Ibrahim SahinOkan BakinerAysegul Atmaca Review Open access 27 June 2024 Pages: 1687 - 1716
Expert Opinion on Optimising Type 2 Diabetes Treatment Using Fixed-Ratio Combination of Basal Insulin and GLP-1 RA for Treatment Intensification and Simplification Martin HaluzikZoltan TaybaniMaciej Malecki Review Open access 27 June 2024 Pages: 1673 - 1685
Impact of Initial Treatment Policies on Long-term Complications and Costs in Japanese Patients with Type 2 Diabetes: A Real-World Database Study Hiroshi YoshiharaTohru TonoikeAtaru Igarashi Original Research Open access 25 June 2024 Pages: 1811 - 1820
Triglyceride Glucose Index for the Detection of Diabetic Kidney Disease and Diabetic Peripheral Neuropathy in Hospitalized Patients with Type 2 Diabetes Zhihui TuJuan DuShan Huang Original Research Open access 22 June 2024 Pages: 1799 - 1810
Frequency and Severity of Hypoglycemia Under Conditions of Increased Hypoglycemic Risk with Insulin Efsitora Alfa Versus Insulin Glargine Treatment in Participants with Type 2 Diabetes Tim HeiseGrit AndersenRichard M. Bergenstal Original Research Open access 22 June 2024 Pages: 1785 - 1797
Perspective of Continuous Glucose Monitoring-Based Interventions at the Various Stages of Type 2 Diabetes R. A. AjjanS. SeiduJ. P. Riveline Commentary Open access 22 June 2024 Pages: 1657 - 1672
Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc Analysis Wolfgang LandgrafDavid R. OwensGeremia B. Bolli Original Research Open access 15 June 2024 Pages: 1769 - 1784
